These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 11193794)
1. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Selkoe DJ Ann N Y Acad Sci; 2000; 924():17-25. PubMed ID: 11193794 [TBL] [Abstract][Full Text] [Related]
2. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD. Thal DR; Fändrich M Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324 [No Abstract] [Full Text] [Related]
3. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease. Armstrong RA Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780 [TBL] [Abstract][Full Text] [Related]
13. The neurobiology and pharmacotherapy of Alzheimer's disease. Felician O; Sandson TA J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552 [TBL] [Abstract][Full Text] [Related]
14. Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement. Musiek ES; Holtzman DM Curr Opin Neurol; 2012 Dec; 25(6):715-20. PubMed ID: 23041958 [TBL] [Abstract][Full Text] [Related]
15. Individual severity of AD-type lesions, Aß oligomers, and comorbidity in the brain aging. Bouras C; Kovari E; Savioz A; Giacobini E; Xekardaki A Adv Exp Med Biol; 2015; 822():17. PubMed ID: 25416972 [No Abstract] [Full Text] [Related]
16. Untangling Alzheimer's disease from fibrous lesions of neurofibrillary tangles and senile plaques. Mori H Neuropathology; 2000 Sep; 20 Suppl():S55-60. PubMed ID: 11037189 [TBL] [Abstract][Full Text] [Related]
17. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
19. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Patrick E; Rajagopal S; Wong HA; McCabe C; Xu J; Tang A; Imboywa SH; Schneider JA; Pochet N; Krichevsky AM; Chibnik LB; Bennett DA; De Jager PL Mol Neurodegener; 2017 Jul; 12(1):51. PubMed ID: 28668092 [TBL] [Abstract][Full Text] [Related]
20. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease. Wilcock DM CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]